Macclesfield, United Kingdom

Philip J Jewbury

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip J Jewbury. Retrieved from https://idiyas.com/inventor/philip-j-jewbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 192(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Philip J Jewbury

Introduction

Philip J Jewbury is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-cell proliferative activity. His work has implications for cancer treatment and other medical applications.

Latest Patents

Jewbury holds a patent for 2,4-diamino pyrimidine compounds that exhibit anti-cell proliferative activity. This innovation is crucial in the ongoing search for effective treatments against various forms of cancer. His patent portfolio includes 1 patent that showcases his expertise in medicinal chemistry.

Career Highlights

Jewbury is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Jewbury has collaborated with esteemed colleagues such as Robert Hugh Bradbury and Gloria Anne Breault. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Philip J Jewbury's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapies that can potentially save lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…